Disseminated intravascular coagulation in Stevens-Johnson syndrome and toxic epidermal necrolysis
Published: 15 August 2020| Version 1 | DOI: 10.17632/gpcj4b3wtk.1
Contributors:
Chun-Bing Chen, Tsun-Hao Hsu, Rosaline Chung-Yee Hui, Chun-Wei Lu, Wei-Ti Chen, Pin-Hsuan Chiang, Chuang-Wei Wang, Shiow-Shuh Chuang, Jui-Yung Yang, Shu-Ying Chang, Yen-Chang Hsiao, Kuo-Chin Kao, Han-Chung Hu, Ting-Shu Wu, Chao-Wei Hsu, David Hui-Kang Ma, Shin-Yi Chen, Ya-Chung Tian, Chi-Yuan Cheng, Chi-Hua Chen, Ming-Hui Chi, Ming-Ying Wu, Ren-Feng Liu, Chi-Hui Wang, Ya-Ging Chang, Jing-Yi Lin, Hsin-Chun Ho, Yang Yu-Wei Lin, Chee Jen Chang, Yu-Jr Lin, Cheng-Lung Ku, Shuen-Iu Hung, Wen-Hung ChungDescription
Supplemental information Tables: 2 Figures: 3 Supplement Table 1. Demographic data of patients with SJS/TEN enrolled in this study (n=150) Supplement Table 2. Microorganisms in SJS/TEN patients with DIC (n=32) Supplement Fig 1. Flow chart of patient enrollment in the study. Supplement Fig 2. Clinical presentation of two toxic epidermal necrolysis (TEN) patients with and without disseminated intravascular coagulation (DIC) Supplement Fig 3. Demonstration of the disseminated intravascular coagulation score in 7 deceased and 7 survived Stevens-Johnson syndrome/toxic epidermal necrolysis patients.
Files
Institutions
- Chang Chun University
Categories
Dermatology, Drug Adverse Reactions, Disseminated Intravascular Coagulation, Drug Hypersensitivity, Coagulopathy, Toxic Epidermal Necrolysis